CASP3 and hepatocellular carcinoma: For hepatocellular carcinoma HCC treatment, BZN combined with endoxan led to significant increase of caspase-3-mediated apoptosis and remarkable decrease in diethylnitrosamine (DEN) induced primary HCC in rats (Abozaid et al., 2020).